Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use

Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia

(2014) Cathleen Michelle A. Dee et al.   BRITISH JOURNAL OF HAEMATOLOGY

Deferasirox nephrotoxicity—the knowns and unknowns

(2014) Juan Daniel Díaz-García et al.   Nature Reviews Nephrology

Renal hemosiderosis and rapidly progressive glomerulonephritis associated with primary hemochromatosis

(2014) Sultan Ozkurt et al.   RENAL FAILURE

Hyperchloraemic metabolic acidosis induced by the iron chelator deferasirox: a case report and review of the literature

(2013) V. G. Dell'Orto et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Refractory anemia leading to renal hemosiderosis and renal failure

(2011) Sujatha Siddappa et al.   Indian Journal of Pathology and Microbiology

Acquired Proximal Renal Tubular Dysfunction in β-Thalassemia Patients Treated With Deferasirox

(2010) Joanne Yacobovich et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Renal Fanconi Syndrome Secondary to Deferasirox: Where There Is Smoke There Is Fire

(2010) Michel Baum   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Acute renal failure and Fanconi syndrome due to deferasirox

(2010) S. Grange et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Reversible Fanconi syndrome in a pediatric patient on deferasirox

(2010) Michelle N. Rheault et al.   PEDIATRIC BLOOD & CANCER

Fanconi syndrome in a patient with β-thalassemia major after using deferasirox for 27 months

(2010) Hsin-Yi Wei et al.   TRANSFUSION

Fanconi Syndrome Due to Deferasirox

(2009) Cédric Rafat et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Hyperchloremic Metabolic Acidosis Due to Deferasirox in a Patient with Beta Thalassemia Major

(2009) Nikolaos Papadopoulos et al.   ANNALS OF PHARMACOTHERAPY

Oral iron chelation and the treatment of iron overload in a pediatric hematology center

(2009) Jean L. Raphael et al.   PEDIATRIC BLOOD & CANCER